Literature DB >> 26783291

Exploring Issues of Comorbid Conditions in People Who Smoke.

Alana M Rojewski1, Stephen Baldassarri2, Nina A Cooperman3, Ellen R Gritz4, Frank T Leone5, Megan E Piper6, Benjamin A Toll7, Graham W Warren8.   

Abstract

UNLABELLED: Smoking affects comorbid disease outcomes, and patients with comorbid conditions may have unique characteristics that are important to consider when treating tobacco use. However, addressing tobacco in patients being treated for comorbid conditions is not a consistent practice. Recognizing the need for a "call-to-action" to address tobacco use in people with comorbid conditions, the Tobacco Treatment Network within the Society for Research on Nicotine and Tobacco (SRNT) convened a Comorbidities Workgroup to explore the relationship between smoking and comorbid disease to identify common themes including: the harms associated with continued tobacco use, the frequency of comorbid disease and tobacco use, the potential effect of comorbid disease on the ability to quit tobacco use, the association between tobacco use and suboptimal disease-specific treatment response, and evidence regarding potential approaches to improve addressing tobacco use in patients with comorbid disease. Five candidate conditions (psychiatric, cancer, cardiovascular, pulmonary, and human immunodeficiency virus infected patients) were explored. Across comorbid conditions, smoking adversely affects treatment efficacy and promotes other adverse health conditions. People with comorbid conditions who smoke are motivated to quit and respond to evidence-based smoking cessation treatments. However, tobacco cessation is not regularly incorporated into the clinical care of many individuals with comorbidities. Optimal strategies for addressing tobacco use within each comorbid disease are also not well defined. Further work is needed to disseminate evidence-based care into clinical practice for smokers with comorbid disease and addiction research should consider comorbid conditions as an important construct to explore. IMPLICATIONS: This article explores how physical and psychiatric conditions may interact in the treatment of tobacco dependence, and discusses the need for smoking cessation as a critical component of comorbid condition management. Five common comorbid domains-psychiatric, cancer, pulmonary, cardiovascular, and human immunodeficiency virus (HIV)-are highlighted to illustrate how these different conditions might interact with smoking with respect to prevalence and harm, motivation to quit, and cessation treatment utilization and success.
© The Author 2016. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2016        PMID: 26783291      PMCID: PMC4941598          DOI: 10.1093/ntr/ntw016

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  197 in total

1.  The association between probable personality disorders and smoking cessation and maintenance.

Authors:  Bárbara Piñeiro; Elena Fernández Del Río; Ana López-Durán; Ursula Martínez; Elisardo Becoña
Journal:  Addict Behav       Date:  2013-04-03       Impact factor: 3.913

2.  A randomized trial for hazardous drinking and smoking cessation for callers to a quitline.

Authors:  Benjamin A Toll; Steve Martino; Stephanie S O'Malley; Lisa M Fucito; Sherry A McKee; Christopher W Kahler; Alana M Rojewski; Martin C Mahoney; Ran Wu; Paula Celestino; Srinivasa Seshadri; James Koutsky; Andrew Hyland; K Michael Cummings
Journal:  J Consult Clin Psychol       Date:  2014-11-24

3.  The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease.

Authors:  A M Joseph; S M Norman; L H Ferry; A V Prochazka; E C Westman; B G Steele; S E Sherman; M Cleveland; D O Antonuccio; D O Antonnucio; N Hartman; P G McGovern
Journal:  N Engl J Med       Date:  1996-12-12       Impact factor: 91.245

4.  Cigarette smoking behaviors and beliefs in persons living with HIV/AIDS.

Authors:  Jonathan Shuter; Steven L Bernstein; Alyson B Moadel
Journal:  Am J Health Behav       Date:  2012-01

Review 5.  Tobacco use and cessation for cancer survivors: an overview for clinicians.

Authors:  Maher Karam-Hage; Paul M Cinciripini; Ellen R Gritz
Journal:  CA Cancer J Clin       Date:  2014-05-09       Impact factor: 508.702

6.  Open revascularization procedures are more likely to influence smoking reduction than percutaneous procedures.

Authors:  Sareh Rajaee; Leonid Cherkassky; Edward J Marcaccio; Wilfred I Carney; Tze Tec Chong; Manuel Garcia-Toca; Jeffrey M Slaiby
Journal:  Ann Vasc Surg       Date:  2013-10-27       Impact factor: 1.466

7.  Long-term outcomes of a cell phone-delivered intervention for smokers living with HIV/AIDS.

Authors:  Ellen R Gritz; Heather E Danysh; Faith E Fletcher; Irene Tami-Maury; Michelle Cororve Fingeret; Rachel Marks King; Roberto C Arduino; Damon J Vidrine
Journal:  Clin Infect Dis       Date:  2013-05-23       Impact factor: 9.079

8.  Nicotine dependence treatment during inpatient treatment for other addictions: a prospective intervention trial.

Authors:  R D Hurt; K M Eberman; I T Croghan; K P Offord; L J Davis; R M Morse; M A Palmen; B K Bruce
Journal:  Alcohol Clin Exp Res       Date:  1994-08       Impact factor: 3.455

Review 9.  Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews.

Authors:  Jamie Hartmann-Boyce; Lindsay F Stead; Kate Cahill; Tim Lancaster
Journal:  Addiction       Date:  2014-07-04       Impact factor: 6.526

Review 10.  Systematic review and meta-analysis: influence of smoking cessation on incidence of pneumonia in HIV.

Authors:  Preeti De; Amanda Farley; Nicola Lindson; Paul Aveyard
Journal:  BMC Med       Date:  2013-01-22       Impact factor: 8.775

View more
  17 in total

1.  Extended Nicotine Patch Treatment Among Smokers With and Without Comorbid Psychopathology.

Authors:  Allison J Carroll; Amanda R Mathew; Frank T Leone; E Paul Wileyto; Andrew Miele; Robert A Schnoll; Brian Hitsman
Journal:  Nicotine Tob Res       Date:  2020-01-27       Impact factor: 4.244

2.  The Bad and Good News About Tobacco Treatment for People With Comorbid Conditions in the US Health Care System.

Authors:  Jennifer W Tidey
Journal:  Nicotine Tob Res       Date:  2019-10-26       Impact factor: 4.244

Review 3.  Electronic Cigarettes: Past, Present, and Future: What Clinicians Need to Know.

Authors:  Stephen R Baldassarri
Journal:  Clin Chest Med       Date:  2020-12       Impact factor: 2.878

Review 4.  The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19.

Authors:  Ali Ehsan Sifat; Saeideh Nozohouri; Heidi Villalba; Bhuvaneshwar Vaidya; Thomas J Abbruscato
Journal:  J Pharmacol Exp Ther       Date:  2020-10-08       Impact factor: 4.030

Review 5.  Considering Systemic Barriers to Treating Tobacco Use in Clinical Settings in the United States.

Authors:  Alana M Rojewski; Steffani R Bailey; Steven L Bernstein; Nina A Cooperman; Ellen R Gritz; Maher A Karam-Hage; Megan E Piper; Nancy A Rigotti; Graham W Warren
Journal:  Nicotine Tob Res       Date:  2019-10-26       Impact factor: 4.244

6.  Lifetime Depression, Other Mental Illness, and Smoking Cessation.

Authors:  Amanda L Huffman; Julie E Bromberg; Erik M Augustson
Journal:  Am J Health Behav       Date:  2018-07-01

7.  Smoking Cessation in Stroke Survivors in the United States: A Nationwide Analysis.

Authors:  Neal S Parikh; Melvin Parasram; Halina White; Alexander E Merkler; Babak B Navi; Hooman Kamel
Journal:  Stroke       Date:  2021-11-17       Impact factor: 7.914

8.  Assessing Sex, Gender Identity, Sexual Orientation, Race, Ethnicity, Socioeconomic Status, and Mental Health Concerns in Tobacco Use Disorder Treatment Research: Measurement Challenges and Recommendations From a Society for Research on Nicotine and Tobacco Pre-conference Workshop.

Authors:  Andrea H Weinberger; Marc L Steinberg; Sarah D Mills; Sarah S Dermody; Jaimee L Heffner; Amanda Y Kong; Raina D Pang; Rachel L Rosen
Journal:  Nicotine Tob Res       Date:  2022-03-26       Impact factor: 5.825

9.  Water-pipe smoking promotes epithelial-mesenchymal transition and invasion of human breast cancer cells via ERK1/ERK2 pathways.

Authors:  Khaled W Sadek; Mahmoud Y Haik; Anas A Ashour; Tahira Baloch; Tahar Aboulkassim; Amber Yasmeen; Semir Vranic; Asad Zeidan; Ala-Eddin Al Moustafa
Journal:  Cancer Cell Int       Date:  2018-11-13       Impact factor: 5.722

10.  Socioeconomic Disadvantage and Other Risk Factors for Using Higher-Nicotine/Tar-Yield (Regular Full-Flavor) Cigarettes.

Authors:  Stephen T Higgins; Ryan Redner; Jeff S Priest; Janice Y Bunn
Journal:  Nicotine Tob Res       Date:  2017-11-07       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.